Drug Manufacturer Fraud Litigation, Fraud - Written by Beasley Allen on Tuesday, November 8, 2011 14:41 - 0 Comments

Johnson & Johnson Unit Agrees To $85 Million Fine For Misbranding Drug

Johnson & Johnson’s Scios unit has agreed to pay an $85 million fine and plead guilty to misbranding the heart drug Natrecor. Scios was charged in July with misbranding the medicine because its labeling lacked adequate directions for use. Under a plea agreement reached after months of negotiation with prosecutors, Scios will be placed under organizational probation for three years in addition to paying the fine. The was filed in federal court in San Francisco and approved by the court.



Leave a Reply

Comment

Comments are moderated and generally will be posted if they are on-topic and not abusive.

Powered by WP Hashcash

Recent Settlements - Feb 9, 2012 7:09 - 0 Comments

Settlement In BTSI Defect Case

More In Recent Settlements


Liability, Personal Injury, Product Liability - May 2, 2013 8:56 - 0 Comments

Kentucky Jury Awards Significant Damages In Defective Cochlear Implant Case

More In Product Liability


Recalls Update - May 3, 2013 9:23 - 0 Comments

Natura Pet Expands Recall Of Dry Pet Foods

More In Recalls Update